miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH, Chen ZN, Li-Li, Chen J, Wei WE, Mo XW, Qin YZ, Lin Y, Chen JS.
Yan LH, et al. Among authors: chen j, chen zn, chen js.
Oncotarget. 2016 Oct 25;7(43):70699-70714. doi: 10.18632/oncotarget.12208.
Oncotarget. 2016.
PMID: 27683111
Free PMC article.